52 related articles for article (PubMed ID: 12680487)
1. Sulfonamide Drug Allergy.
Dorn JM; Alpern M; McNulty C; Volcheck GW
Curr Allergy Asthma Rep; 2018 Jun; 18(7):38. PubMed ID: 29876667
[TBL] [Abstract][Full Text] [Related]
2. New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.
Paquet P; Piérard GE
Drug Saf; 2010 Mar; 33(3):189-212. PubMed ID: 20158284
[TBL] [Abstract][Full Text] [Related]
3. Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England.
Layton D; Marshall V; Boshier A; Friedmann P; Shakir SA
Drug Saf; 2006; 29(8):687-96. PubMed ID: 16872242
[TBL] [Abstract][Full Text] [Related]
4. Valdecoxib: a review of its use in the management of osteoarthritis, rheumatoid arthritis, dysmenorrhoea and acute pain.
Fenton C; Keating GM; Wagstaff AJ
Drugs; 2004; 64(11):1231-61. PubMed ID: 15161329
[TBL] [Abstract][Full Text] [Related]
5. Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Cartotto R
Clin Plast Surg; 2017 Jul; 44(3):583-595. PubMed ID: 28576247
[TBL] [Abstract][Full Text] [Related]
6. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
[TBL] [Abstract][Full Text] [Related]
8. Stevens-Johnson Syndrome: A Challenging Diagnosis.
Davis WD; Schafer PA
Adv Emerg Nurs J; 2018; 40(3):176-182. PubMed ID: 30059372
[TBL] [Abstract][Full Text] [Related]
9. A cautionary note when using zonisamide in youths: a case report of association with toxic epidermal necrolysis.
Majeres KD; Suppes T
J Clin Psychiatry; 2004 Dec; 65(12):1720. PubMed ID: 15641880
[No Abstract] [Full Text] [Related]
10. Valdecoxib-induced toxic epidermal necrolysis in a patient allergic to sulfa drugs.
Glasser DL; Burroughs SH
Pharmacotherapy; 2003 Apr; 23(4):551-3. PubMed ID: 12680487
[TBL] [Abstract][Full Text] [Related]
11. Use of intravenous immunoglobulin for Stevens-Johnson syndrome and toxic epidermal necrolysis in children: Report of two cases secondary to anticonvulsants.
Romero-Tapia SJ; Cámara-Combaluzier HH; Baeza-Bacab MA; Cerino-Javier R; Bulnes-Mendizabal DP; Virgen-Ortega C
Allergol Immunopathol (Madr); 2015; 43(2):227-9. PubMed ID: 25183634
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
